13F

Stock

Zentalis Pharmaceuticals, Inc.

ZNTL · held by 2 managers

Reported value

$68

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$1

Price effect on 1 books still in the name

Largest holder

$67

Essential Partners LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Essential Partners LLC58$67Held
BARCLAYS PLC1$1−$1Cut−$94.8K

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.